Clinical Trial Update: FACBC PET/CT for Recurrent Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results for FACBC PET/CT in detecting recurrent prostate cancer have been completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• FACBC PET/CT (fluciclovine F-18) (fluciclovine F-18)

Snippet

Sponsor: David M. Schuster, MD | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-08-18